Blogs
Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.

GLP-1 agonists

The articles shown below are all about the GLP-1 agonists, through these related articles, you can get relevant information, notes in use, or latest trends about the GLP-1 agonists. We hope these news will give you the help you need. And if these GLP-1 agonists articles can't solve your needs, you can contact us for relevant information.
  • Cost is King: Why Small Molecule GLP-1 Drugs Are Gaining Popularity in Developing Countries

    Cost is King: Why Small Molecule GLP-1 Drugs Are Gaining Popularity in Developing Countries

    2025-07-09

    This article explores the growing preference for small molecule GLP-1 receptor agonists in developing countries, driven by cost sensitivity, infrastructure limitations, and the need for scalable oral therapies for diabetes and obesity. It examines the economic and clinical advantages of small molecules over biologics, analyzes emerging market dynamics, and outlines how Unibest leverages its sourcing, regulatory, and export expertise to support global access. The piece also reviews current pipeline innovations and the future potential of affordable GLP-1 drugs in underserved regions. Read More